XML 181 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash Flows from Operating Activities:      
Net income/(loss) including income attributable to noncontrolling interest $ 1,984 $ 660 $ 206
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:      
Depreciation, amortization, and accretion 757 760 803
Goodwill, Impairment Loss 7 0 0
Origination of mortgage servicing rights (336) (224) (289)
Provisions for credit losses and foreclosed property 1,535 1,664 2,831
Mortgage repurchase provision 713 502 456
Deferred Income Tax Expense (Benefit) 194 83 (171)
Stock option compensation and amortization of restricted stock compensation 35 44 66
Gains (Losses) on Extinguishment of Debt 16 (3) 70
Gain (Loss) on Sale of Securities, Net (1,974) [1] (117) [1] (191) [1],[2]
Net gain on sale of assets (1,063) (408) (597)
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments 0 (88) 0
Net decrease/(increase) in loans held for sale 194 2,234 1,003
Net (increase)/decrease in other assets 974 (497) (341)
Net increase/(decrease) in other liabilities (1,026) 18 372
Net cash provided by operating activities 2,010 4,628 4,218
Cash Flows from Investing Activities:      
Proceeds from maturities, calls, and paydowns of securities available for sale 7,371 5,557 5,597
Proceeds from sales of securities available for sale 4,300 12,557 17,465
Purchases of securities available for sale (5,814) (18,872) (20,920)
Proceeds from maturities, calls, and paydowns of trading securities 3 139 99
Proceeds from sales of trading securities 0 102 132
Net (increase)/decrease in loans including purchases of loans (6,400) (11,034) (4,566)
Proceeds from sales of loans 4,916 747 936
Capital expenditures (206) (131) (252)
Contingent consideration and other payments related to acquisitions (12) (24) (10)
Proceeds from the sale of other assets 585 628 800
Net cash (used in)/provided by investing activities 4,743 (10,331) (719)
Cash Flows from Financing Activities:      
Net (decrease)/increase in total deposits 4,394 4,878 1,182
Net increase/(decrease) in funds purchased, securities sold under agreements to repurchase, and other short-term borrowings (5,972) 6,650 (1,295)
Proceeds from the issuance of long-term debt 4,000 1,749 500
Repayment of long-term debt (5,772) (4,571) (5,246)
Proceeds from the issuance of common stock 0 1,017 0
Proceeds from the issuance of preferred stock 438 103 0
Repurchase of preferred stock 0 (4,850) 0
Purchase of outstanding warrants 0 (11) 0
Common and preferred dividends paid (119) (131) (259)
Stock option activity 26 0 0
Net cash provided by/(used in) financing activities (3,005) 4,834 (5,118)
Net (decrease)/increase in cash and cash equivalents 3,748 (869) (1,619)
Cash and cash equivalents at beginning of period 4,509 5,378 6,997
Cash and cash equivalents at end of period 8,257 4,509 5,378
Supplemental Disclosures:      
Interest paid 774 1,138 1,537
Income Taxes Paid 607 68 33
Income taxes refunded (1) (1) (435)
Loans transferred from loans held for sale to loans 71 63 213
Loans transferred from loans to loans held for sale 3,695 754 346
Transfer to Other Real Estate 399 725 1,063
Amortization Of Deferred Gain On Sale Lease Back Of Premises 67 59 59
Accretion of discount for preferred stock issued to the U.S. Treasury 0 80 25
Supplemental Consolidation Of Variable Interest Entity $ 0 $ 0 $ 2,541
[1] Includes credit-related OTTI losses of $7 million, $6 million and $2 million, including $6 million, $4 million, and $0 of unrealized losses reclassified from OCI, before taxes, for the years ended December 31, 2012, 2011, and 2010, respectively.
[2] Includes dividends on the Coke common stock of $31 million, $56 million, and $53 million, for the years ended December 31, 2012, 2011, and 2010, respectively.